🔥🔥20kr Q2🔥🔥 39 new products Mai 2021
Solskjær-satsing får grønt lys i Saudi-Arabia
Aqua Bio Technologys hudpleieprodukter er på vei inn i et marked der det årlig omsettes for 130 milliarder kroner.
Aksjeanalyser.com har i dag sett nærmere igjen på et av de mindre, men likevel svært spennende selskapene på Oslo Børs, Aqua Bio Technology ASA (ticker på Oslo Børs, Euronext Expand: ABT).
Aksjeanalyser.com ser et potensiale for aksjen opp mot NOK 15.00 – 20.00 og det i løpet av relativt kort tid (1måneder).
årsrapporten kommer neste uke bull.
13.5kr nå...røverkjøp.
Finansiell kalender
Finansiell kalender for Aqua Bio Technology ASA
REGNSKAPSÅR 2020
14.04.2021 - Årsrapport
Ellers så anbefales det å lese saken her fra E24 i forrige uke, og som er svært interessant med tanke på Aqua Bio Technology og som leverer nettopp produkter til kosmetikkindustrien og til egne produkter som gjør at man unngår å bruke bl.a. mikroplast i produktene:
Greenpeace vil ha plastforbud i kosmetikk
Tre av fire prøver fra velrenommerte kosmetikkmerker inneholdt mikroplast. Nå tar Greenpeace Tyskland til orde for et forbud mot mikroplast i kosmetikk. Greenpeace Norge støtter forbudet og vil at EU skal gå i bresjen.
– Frivillige tiltak fra selskapene for å fjerne plasten virker ikke, heter det i en ny Greenpeace-rapport.
Tyske Greenpeace undersøkte 664 produkter, og fant mikroplast i 502. Det betyr at 76 prosent av produktene inneholdt mikroplast. Produktene som ble testet kom fra elleve velrenommerte kosmetikkprodusenter.
En firedel av produktene inneholdt mikroplast, mens resten inneholdt plast i flytende, halvfast eller oppløselig form.
Greenpeace Norge har lenge jobbet for å få på plass et internasjonalt forbud mot mikroplast i kosmetikk og hygieneprodukter.
Kilde og hvor dere kan lese hele denne saken: https://e24.no/det-groenne-skiftet/i/9O1QK5/greenpeace-vil-ha-plastforbud-i-kosmetikk
Commercial update Aqua Bio Technology (ABT)
30.04.2021 08:33
https://newsweb.oslobors.no/message/531782
30.4.2021 08:33:04 CEST | Aqua Bio Technology ASA | Non-regulatory press
releases
Products series from DCP Dermosciense (DCP)
Seidr and Seidr Cliniq have now passed all safety studies, which means that the
Seidr series (39 products in total) will be ready for distribution and sale in
q2 2021. See the first pictures from the series in Appendix 1.
Sister brand from Moana Skincare - B Natural
B Natural is based on the same unique ingredients as Moana Skincare and has been
created to adapt the product to other markets, expanding the commercial reach of
the unique Moana product line. The B Natural series (21 products in total ) is
ready for distribution and sale in q2 2021. See the first pictures from the
series in Appendix 1.
Update on new e-commerce website for ABT
ABT is launching a new e-commerce website in q2of 2021 containing all ABT
skincare products for shareholder and certain customers and will have B2B log in
for ABT's distributors
Restorsea's commercialization of ABT's hatching fluid ingredient (Aquabeautine
XL)
ABT's US partner Restorsea has invested large sums -
https://ir.lifemd.com/press-release-details.php#/?newsId=2114190 for the
exclusive right to use ABT's hatching fluid ingredient as the main ingredient in
its own and licensed products. As informed 8 of February 2021 -
https://newsweb.oslobors.no/message/524073 Hydrafacial officially announced its
partnership with Restorsea and launched in Q1 2021 its new Restorsea Lip Fix Kit
which is based on ABT's hatching fluid ingredient (Aquabeautine XL).
LifeMD (former Conversion Labs) presented NavaMD -
https://ir.lifemd.com/press-release-details.php#/?newsId=2205885 and its
cooperation with Restorsea in Q1 2021 and ABT expecting that the NavaMD products
containing Aquabeautine XL -
https://ir.lifemd.com/press-release-details.php#/?newsId=2114190 will be
launched in the near future.
The positive trend from Restorsea's commercialization of ABT's proprietary
technology increases the likelihood that ABT will receive additional renewal
payment and increased revenue from the sale of ingredients and royalties.
Pre launch of ABT`s products
ABT is planning a pre-launch of ABT's products in q2 and shareholders that would
like to learn more about the products and participate in the pre-launch should
subscribe and register on ABT`s website -
https://aquabiotechnology.com/pages/subscription to receive examples of our new
products.
For further information, please contact CEO Espen Kvale, telephone +47 9162
8092.
* * *
Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. ABT's focus on commercialization and development of natural
ingredients and natural skin care products has been, and will continue to be, an
important part of the Company's strategy going forward.
Aqua Bio Technology is listed on the Euronext Expand market of the Oslo Stock
Exchange.
This information was considered to be inside information pursuant to the EU
Market Abuse Regulation and is subject to the disclosure requirements pursuant
to section 5-12 of the Norwegian Securities Trading Act. The stock exchange
announcement was published by Håvard Lindstrøm, Head of Business Development, on
30 April 2021, at 08.30 CES
DISCLOSURE REGULATION
This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.
CONTACTS
* Espen Kvale, CEO, +47 916 28 092, espen.kvale@aquabiotech.no
ABOUT AQUA BIO TECHNOLOGY ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.
ATTACHMENTS
Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/514/655/Download%20announcement%2
0as%20PDF.pdf
ABT stock exchange message appendix 30 April 2021.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/514/654/ABT%20stock%20exchange%20
message%20appendix%2030%20April%202021.pdf
Aqua Bio Technologys hudpleieprodukter er på vei inn i et marked der det årlig omsettes for 130 milliarder kroner.
Aksjeanalyser.com har i dag sett nærmere igjen på et av de mindre, men likevel svært spennende selskapene på Oslo Børs, Aqua Bio Technology ASA (ticker på Oslo Børs, Euronext Expand: ABT).
Aksjeanalyser.com ser et potensiale for aksjen opp mot NOK 15.00 – 20.00 og det i løpet av relativt kort tid (1måneder).
årsrapporten kommer neste uke bull.
13.5kr nå...røverkjøp.
Finansiell kalender
Finansiell kalender for Aqua Bio Technology ASA
REGNSKAPSÅR 2020
14.04.2021 - Årsrapport
Ellers så anbefales det å lese saken her fra E24 i forrige uke, og som er svært interessant med tanke på Aqua Bio Technology og som leverer nettopp produkter til kosmetikkindustrien og til egne produkter som gjør at man unngår å bruke bl.a. mikroplast i produktene:
Greenpeace vil ha plastforbud i kosmetikk
Tre av fire prøver fra velrenommerte kosmetikkmerker inneholdt mikroplast. Nå tar Greenpeace Tyskland til orde for et forbud mot mikroplast i kosmetikk. Greenpeace Norge støtter forbudet og vil at EU skal gå i bresjen.
– Frivillige tiltak fra selskapene for å fjerne plasten virker ikke, heter det i en ny Greenpeace-rapport.
Tyske Greenpeace undersøkte 664 produkter, og fant mikroplast i 502. Det betyr at 76 prosent av produktene inneholdt mikroplast. Produktene som ble testet kom fra elleve velrenommerte kosmetikkprodusenter.
En firedel av produktene inneholdt mikroplast, mens resten inneholdt plast i flytende, halvfast eller oppløselig form.
Greenpeace Norge har lenge jobbet for å få på plass et internasjonalt forbud mot mikroplast i kosmetikk og hygieneprodukter.
Kilde og hvor dere kan lese hele denne saken: https://e24.no/det-groenne-skiftet/i/9O1QK5/greenpeace-vil-ha-plastforbud-i-kosmetikk
Commercial update Aqua Bio Technology (ABT)
30.04.2021 08:33
https://newsweb.oslobors.no/message/531782
30.4.2021 08:33:04 CEST | Aqua Bio Technology ASA | Non-regulatory press
releases
Products series from DCP Dermosciense (DCP)
Seidr and Seidr Cliniq have now passed all safety studies, which means that the
Seidr series (39 products in total) will be ready for distribution and sale in
q2 2021. See the first pictures from the series in Appendix 1.
Sister brand from Moana Skincare - B Natural
B Natural is based on the same unique ingredients as Moana Skincare and has been
created to adapt the product to other markets, expanding the commercial reach of
the unique Moana product line. The B Natural series (21 products in total ) is
ready for distribution and sale in q2 2021. See the first pictures from the
series in Appendix 1.
Update on new e-commerce website for ABT
ABT is launching a new e-commerce website in q2of 2021 containing all ABT
skincare products for shareholder and certain customers and will have B2B log in
for ABT's distributors
Restorsea's commercialization of ABT's hatching fluid ingredient (Aquabeautine
XL)
ABT's US partner Restorsea has invested large sums -
https://ir.lifemd.com/press-release-details.php#/?newsId=2114190 for the
exclusive right to use ABT's hatching fluid ingredient as the main ingredient in
its own and licensed products. As informed 8 of February 2021 -
https://newsweb.oslobors.no/message/524073 Hydrafacial officially announced its
partnership with Restorsea and launched in Q1 2021 its new Restorsea Lip Fix Kit
which is based on ABT's hatching fluid ingredient (Aquabeautine XL).
LifeMD (former Conversion Labs) presented NavaMD -
https://ir.lifemd.com/press-release-details.php#/?newsId=2205885 and its
cooperation with Restorsea in Q1 2021 and ABT expecting that the NavaMD products
containing Aquabeautine XL -
https://ir.lifemd.com/press-release-details.php#/?newsId=2114190 will be
launched in the near future.
The positive trend from Restorsea's commercialization of ABT's proprietary
technology increases the likelihood that ABT will receive additional renewal
payment and increased revenue from the sale of ingredients and royalties.
Pre launch of ABT`s products
ABT is planning a pre-launch of ABT's products in q2 and shareholders that would
like to learn more about the products and participate in the pre-launch should
subscribe and register on ABT`s website -
https://aquabiotechnology.com/pages/subscription to receive examples of our new
products.
For further information, please contact CEO Espen Kvale, telephone +47 9162
8092.
* * *
Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. ABT's focus on commercialization and development of natural
ingredients and natural skin care products has been, and will continue to be, an
important part of the Company's strategy going forward.
Aqua Bio Technology is listed on the Euronext Expand market of the Oslo Stock
Exchange.
This information was considered to be inside information pursuant to the EU
Market Abuse Regulation and is subject to the disclosure requirements pursuant
to section 5-12 of the Norwegian Securities Trading Act. The stock exchange
announcement was published by Håvard Lindstrøm, Head of Business Development, on
30 April 2021, at 08.30 CES
DISCLOSURE REGULATION
This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.
CONTACTS
* Espen Kvale, CEO, +47 916 28 092, espen.kvale@aquabiotech.no
ABOUT AQUA BIO TECHNOLOGY ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.
ATTACHMENTS
Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/514/655/Download%20announcement%2
0as%20PDF.pdf
ABT stock exchange message appendix 30 April 2021.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/514/654/ABT%20stock%20exchange%20
message%20appendix%2030%20April%202021.pdf
Redigert 03.05.2021 kl 08:29
Du må logge inn for å svare
janhen
21.04.2021 kl 16:36
3492
Det var litt av en svingom i dag. Fylte på litt på 11.35, alt under 11.45 håper jeg er bra:) Vært noen heftige børsdager
LPI
23.04.2021 kl 10:44
3349
AQUA BIO TECHNOLOGY receives green light from Al DAWAA pharmacies Aqua Bio Technology ASA ("ABT") has been informed by the second largest pharmacy chain in Saudi Arabia, Al Dawaa Pharmacies ("Al Dawaa"), that they are ready to distribute Moana Skincare to around 50 pharmacies across Saudi Arabia with the possibility of expanding to more stores provided that ABT, among other things, obtains approval from the Saudi Arabian authorities for the sale of the Moana Skincare products. I
Bomerang
26.04.2021 kl 10:36
3145
Blev ikke noen oppgang på fredag etter gomelding??? Og ikke idag???
Bomerang
26.04.2021 kl 11:29
3119
Mr Big skrev Kanon:). Dette blir bra folkens.
Blev ikke noen oppgang på fredag etter gomelding??? Og ikke idag???
Mr Big
29.04.2021 kl 09:19
2768
Så stille her. Ser noen driver og lemper ut aksjer. Innside info igjen eller?
Aksjeamatøren
29.04.2021 kl 09:25
2751
Vel heller at hausing førte til at mange heiv seg på aksjen. Og nå selger de utålmodige og alle som kastet seg på blir usikre og trykker på salgsknappen.
Tror denne kan bli bra framover mot høsten og neste år, men har ikke kjøpt meg inn igjen enda.
Tror denne kan bli bra framover mot høsten og neste år, men har ikke kjøpt meg inn igjen enda.
Aksjeamatøren
29.04.2021 kl 10:31
2681
Å? Rapporten kommer nok ikke med kanontall ettersom de fleste kontrakter og inntekter ikke vil rulle inn før til høsten og utover. Hvor langt fram i tid skal dette prises inn og det er heller ingen garanti for salget, men oppsiden på disse kursene er tilstede. De fleste som kjøper aksjer som drar opp kursen (småsparer og lykkejegere for raske gevinst) sitter i aksjer 2-3mnd før aksjen blir "kjedelig". Håper på fin guiding og tror på flere gode kjøpsmuligheter før kursen eventuelt vil ta av.
AQUA BIO TECHNOLOGY: board issuance of offer shares in completed private placement 29.4.2021 16:59:54 CEST | Aqua Bio Technology ASA | Inside information
AQUA BIO TECHNOLOGY: board issuance of offer shares in completed private placement
Reference is made to the stock exchange announcement by Aqua Bio Technology (the "Company or ABT") on 15 April 2021 regarding the completion of a private placement raising gross proceeds of up to approximately NOK 15 million (the "Private Placement") at a fixed subscription price of NOK 11.45 per new share (the "Offer Shares") towards Akvakulturpartner AS, an investment company which focuses on attractive and innovate aquaculture opportunities, and certain other external investors.
The interest for the Private Placement was high and the Offer Shares were significantly oversubscribed the same afternoon. The Company values the support from Akvakulturpartner AS, the other investors who subscribed for the Offer Shares and the continued support from its shareholders in the Company's ambition to grow by developing its products.
-The interest in the Private Placement demonstrated that we have confidence in the market. We are experiencing exciting times at ABT, both in product development and commercialization of our products, says CEO Espen Kvale of ABT.
The Company's board of directors has today formally resolved to issue the Offer Shares in the Private Placement pursuant to available board authorizations to settle the share lending arrangement with shareholder Kjeveortoped Espen Dahls AS. Such shares will be issued on a separate, non-tradable ISIN, awaiting approval and publication of a listing prospectus.
For further information, please contact CEO Espen Kvale, telephone +47 9162 8092.
* * *
Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT's cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and professional users. ABT's focus on commercialization and development of natural ingredients and natural skin care products has been, and will continue to be, an important part of the Company's strategy going forward.
Aqua Bio Technology is listed on the Euronext Expand market of the Oslo Stock Exchange.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. The stock exchange announcement was published by Håvard Lindstrøm, Head of Business Development, on 29 April 2021 at 17.00 CET.
Disclosure regulation
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.
Contacts
Espen Kvale
CEO
Tel: +47 916 28 092
espen.kvale@aquabiotech.no
Attachments Download announcement as PDF.pdf About Aqua Bio Technology ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.
Share
Du mottar denne meldingen fordi du abonnerer på innhold fra NTB Kommunikasjon Avslutt epostabonnement
AQUA BIO TECHNOLOGY: board issuance of offer shares in completed private placement
Reference is made to the stock exchange announcement by Aqua Bio Technology (the "Company or ABT") on 15 April 2021 regarding the completion of a private placement raising gross proceeds of up to approximately NOK 15 million (the "Private Placement") at a fixed subscription price of NOK 11.45 per new share (the "Offer Shares") towards Akvakulturpartner AS, an investment company which focuses on attractive and innovate aquaculture opportunities, and certain other external investors.
The interest for the Private Placement was high and the Offer Shares were significantly oversubscribed the same afternoon. The Company values the support from Akvakulturpartner AS, the other investors who subscribed for the Offer Shares and the continued support from its shareholders in the Company's ambition to grow by developing its products.
-The interest in the Private Placement demonstrated that we have confidence in the market. We are experiencing exciting times at ABT, both in product development and commercialization of our products, says CEO Espen Kvale of ABT.
The Company's board of directors has today formally resolved to issue the Offer Shares in the Private Placement pursuant to available board authorizations to settle the share lending arrangement with shareholder Kjeveortoped Espen Dahls AS. Such shares will be issued on a separate, non-tradable ISIN, awaiting approval and publication of a listing prospectus.
For further information, please contact CEO Espen Kvale, telephone +47 9162 8092.
* * *
Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT's cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and professional users. ABT's focus on commercialization and development of natural ingredients and natural skin care products has been, and will continue to be, an important part of the Company's strategy going forward.
Aqua Bio Technology is listed on the Euronext Expand market of the Oslo Stock Exchange.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. The stock exchange announcement was published by Håvard Lindstrøm, Head of Business Development, on 29 April 2021 at 17.00 CET.
Disclosure regulation
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.
Contacts
Espen Kvale
CEO
Tel: +47 916 28 092
espen.kvale@aquabiotech.no
Attachments Download announcement as PDF.pdf About Aqua Bio Technology ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.
Share
Du mottar denne meldingen fordi du abonnerer på innhold fra NTB Kommunikasjon Avslutt epostabonnement
Aksjeanalyser
Grønn aksje stiger kraftig: Kan dobles i rekordfart
Bildet hentet fra hjemmesidene til selskapet Aqua Bio Technology ASA.
"Grønn aksje" til himmels på Oslo Børs og kan stige kraftig videre. Aksjeanalyser.com har sett nærmere
Aksjeanalyser.com ser et stort potensiale for denne aksjen både på kort sikt NOK 18.00 - 20.00 og ser altså en mulig dobling og nær tredobling for denne aksjen i løpet av gjerne bare de neste 3-6 måneder.
Det samlede tekniske bildet for aksjen er nå svært positivt, og et nytt kraftig teknisk kjøpssignal for aksjen utløses nå i dag. Les mer om dette nedenfor i saken her under tekniske analyse av aksjen.
Først her litt kort om selskapet Aqua Bio Technology ASA (ABT):
Kilde: https://aquabiotechnology.com/
Aqua Bio Technology (ABT) is a driving force in the skin care industry’s green shift.
ABT develops new active ingredients for skin care. Our ingredients are meeting an increasing demand from the cosmetics industry. All our ingredients are based on natural and sustainable substances, found in plants, algae and in the oceans. They are sustainable alternatives to petroleum based ingredients, which often have negative impacts on human health and the environment.
ABT also markets and distributes natural and groundbreaking skin care products to consumers, retailers and professionals in Europe and the Middle East.
ABT is well positioned in the fastest growing segment of the rapidly expanding cosmetics industry.
ABT's focus on commercialization and development of natural ingredients and natural skin care products has been, and will continue to be, an important part of the company's strategy going forward. Aqua Bio Technology is listed on Euronext Expand (ticker: ABT).
Her er et par aktuelle og interessante nyheter nå seneste tiden rundt selskapet Aqua Bio Technology ASA (ABT):
18.1.2021, 20:58 Kilde: https://aquabiotechnology.com/
Aqua Bio Technology Asa - Primary Insider Notification
Roger Hofseth has today 18 January 2021 bought 25,000 shares at an average price
of 5.6357 per s
Roger Hofseth is a director and primary insider in Aqua Bio Technology ASA.
After the transaction, Roger Hofseth and related parties will hold 4,039,904
shares corresponding to approximately 21.96 % of the outstanding shares in Aqua
Bio Technology ASA.
Kilde, og hele nyheten kan leses her på selskapets IR hjemmesider som dere finner her: https://aquabiotechnology.com/pages/press-releases-2
Sikkerhetsstudier av 25 produkter fra produktserien Balance & Vitality fullført og godkjent
ABT forventer at produktserien Balance & Vitality er klar for distribusjon og
salg første halvår 2021.
Det vises til børsmelding av 26 november 2020: https://live.euronext.com/nb/listview/company-press-release/146254#CompanyPressRelease-3399798 vedrørende pågående sikkerhetsstudier for produktseriene Nordic
Beauty og Balance & Vitality.
ABT har mottatt bekreftelse på at de 25 første produktene fra Balance & Vitality serien har passert sikkerhetsstudier som EU krever gjennomført før kommersialisering.
Resultatene for siste 3 produkter forventes godkjent i løpet av Q1.
Siden siste børsmelding om utviklingen av produktene har Balance & Vitality serien økt fra 27 til 28 produkter.
Balance & Vitality vil være en komplett hudpleieserie med produkter i alle kategorier.
Testene er utført hos Eurofins [https://www.eurofins.com/about-us/], som er verdens største innenfor testing av mat, miljø, medisin og kosmetikk og har 800 laboratorier i mer enn 50 forskjellige land.
ABT forventer at produktserien Balance & Vitality er klar for distribusjon og salg første halvår 2021.
Kilde, og hele nyheten kan leses her på selskapets IR hjemmesider og som dere finner her: https://aquabiotechnology.com/pages/press-releases-2
Her noen nyttige linker for mer informasjon rundt selskapet og slik som: aksjekurs, nyheter om selskapet, finansiell informasjon, Nøkkeltall, Regnskap, finanskalender, resultatrapporter mv.
Hjemmeside Investor Relations Oslo Børs/Euronext Nordnet
Teknisk Analyse av Aqua Bio Technology ASA (ticker på Oslo Børs, Euronext Expand: ABT)
Aqua Bio Technology ASA (ticker på Oslo Børs: ABT) viser en sterk utvikling innenfor en bratt stigende langsiktig trend (jf. dag og ukediagram).
Redigert 29.04.2021 kl 20:31
Du må logge inn for å svare
0.4.2021 11:24:16 CEST | Aqua Bio Technology ASA | Inside information
Aqua Bio Technology ASA - Primary insider Notification
Håvard Lindstrøm, Head of Business Development and primary insider of Aqua Bio
Technology ASA (the "Company"), has today purchased 11 600 shares at a price of
10.70 per share, through his wholly owned company Ice Capital AS. Following this
purchase, Håvard Lindstrøm and related parties will continue to hold 337 919
shares in the company, corresponding to an ownership stake of 1.83% of the total
outstanding shares in the Company.
For further information, please contact Espen Kvale, CEO, telephone +47 916 28
092.
This information is subject to the disclosure requirements in Regulation EU
596/2014 article 19 number 3 and the Norwegian Securities Trading Act § 5-12.
Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
effective and they provide the cosmetics industry with natural alternatives to
traditional ingredients. ABT is also marketing and distributing natural skin
care products developed by partners towards consumers and professional users.
ABT's focus on commercialization and development of natural ingredients and
natural skin care products has been, and will continue to be, an important part
of the company's strategy going forward. Aqua Bio Technology is listed on
Aqua Bio Technology ASA - Primary insider Notification
Håvard Lindstrøm, Head of Business Development and primary insider of Aqua Bio
Technology ASA (the "Company"), has today purchased 11 600 shares at a price of
10.70 per share, through his wholly owned company Ice Capital AS. Following this
purchase, Håvard Lindstrøm and related parties will continue to hold 337 919
shares in the company, corresponding to an ownership stake of 1.83% of the total
outstanding shares in the Company.
For further information, please contact Espen Kvale, CEO, telephone +47 916 28
092.
This information is subject to the disclosure requirements in Regulation EU
596/2014 article 19 number 3 and the Norwegian Securities Trading Act § 5-12.
Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
effective and they provide the cosmetics industry with natural alternatives to
traditional ingredients. ABT is also marketing and distributing natural skin
care products developed by partners towards consumers and professional users.
ABT's focus on commercialization and development of natural ingredients and
natural skin care products has been, and will continue to be, an important part
of the company's strategy going forward. Aqua Bio Technology is listed on
Solskjær-satsing får grønt lys i Saudi-Arabia
Aqua Bio Technologys hudpleieprodukter er på vei inn i et marked der det årlig omsettes for 130 milliarder kroner.
Aqua Bio Technologys hudpleieprodukter er på vei inn i et marked der det årlig omsettes for 130 milliarder kroner.